1. Home
  2. PNC vs ZTS Comparison

PNC vs ZTS Comparison

Compare PNC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNC
  • ZTS
  • Stock Information
  • Founded
  • PNC 1852
  • ZTS 1952
  • Country
  • PNC United States
  • ZTS United States
  • Employees
  • PNC N/A
  • ZTS N/A
  • Industry
  • PNC Major Banks
  • ZTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNC Finance
  • ZTS Health Care
  • Exchange
  • PNC Nasdaq
  • ZTS Nasdaq
  • Market Cap
  • PNC 74.2B
  • ZTS 66.3B
  • IPO Year
  • PNC N/A
  • ZTS 2013
  • Fundamental
  • Price
  • PNC $194.55
  • ZTS $153.05
  • Analyst Decision
  • PNC Buy
  • ZTS Buy
  • Analyst Count
  • PNC 19
  • ZTS 8
  • Target Price
  • PNC $211.67
  • ZTS $204.63
  • AVG Volume (30 Days)
  • PNC 1.6M
  • ZTS 3.7M
  • Earning Date
  • PNC 07-16-2025
  • ZTS 08-05-2025
  • Dividend Yield
  • PNC 3.50%
  • ZTS 1.31%
  • EPS Growth
  • PNC 22.71
  • ZTS 14.10
  • EPS
  • PNC 14.63
  • ZTS 5.82
  • Revenue
  • PNC $21,240,000,000.00
  • ZTS $9,385,000,000.00
  • Revenue This Year
  • PNC $11.31
  • ZTS $3.63
  • Revenue Next Year
  • PNC $5.49
  • ZTS $6.13
  • P/E Ratio
  • PNC $13.30
  • ZTS $26.31
  • Revenue Growth
  • PNC 4.12
  • ZTS 5.27
  • 52 Week Low
  • PNC $145.12
  • ZTS $139.70
  • 52 Week High
  • PNC $216.26
  • ZTS $200.33
  • Technical
  • Relative Strength Index (RSI)
  • PNC 58.37
  • ZTS 53.39
  • Support Level
  • PNC $186.48
  • ZTS $146.27
  • Resistance Level
  • PNC $190.50
  • ZTS $160.05
  • Average True Range (ATR)
  • PNC 3.07
  • ZTS 3.70
  • MACD
  • PNC -0.12
  • ZTS 0.81
  • Stochastic Oscillator
  • PNC 84.60
  • ZTS 55.70

About PNC PNC Financial Services Group Inc. (The)

PNC Financial Services Group is a diversified financial services company offering retail banking, corporate and institutional banking, asset management, and residential mortgage banking across the United States.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: